Related references
Note: Only part of the references are listed.Drugs for Macular Degeneration, Price Discrimination, and Medicare's Responsibility Not to Overpay
Jonathan Silver
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
The place of medical treatment of acromegaly: current status and perspectives
Raquel S. Jallad et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly Clinical article
Nicholas F. Marko et al.
JOURNAL OF NEUROSURGERY (2012)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes Clinical article
Jason P. Sheehan et al.
JOURNAL OF NEUROSURGERY (2011)
Mortality in Patients with Pituitary Disease
Mark Sherlock et al.
ENDOCRINE REVIEWS (2010)
Radiation treatment strategies for acromegaly
Nathan C. Rowland et al.
NEUROSURGICAL FOCUS (2010)
Quality of life in patients with pituitary tumors
Alicia Santos et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2008)
Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly
Philippe Chanson et al.
CLINICAL ENDOCRINOLOGY (2008)
Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
Maria P. Matta et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
An update on treatment strategies for acromegaly
Laurence Katznelson
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant
S. J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma
Marco Losa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Management of acromegaly: Is there a role for primary medical therapy?
Zachary M. Bush et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Long-term efficacy and safety of combined treatment of somatostatin analogs and Pegvisomant in acromegaly
Sebastian J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Gamma knife stereotactic radiosurgery for acromegaly
Einar Osland Vik-Mo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission
Bruce E. Pollock et al.
JOURNAL OF NEUROSURGERY (2007)
Treatment of acromegaly: is there still a place for radiotherapy?
Raquel S. Jallad et al.
PITUITARY (2007)
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
I. Schreiber et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly
Shih-Che Hua et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly
PJ Jenkins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Outcome of gamma knife radiosurgery in 82 patients with acromegaly:: Correlation with initial hypersecretion
F Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution
RS Jallad et al.
CLINICAL ENDOCRINOLOGY (2005)
Quality of life (QOL) in patients with acromegaly is severely impaired: Use of a novel measure of QOL: Acromegaly Quality of Life Questionnaire
SV Rowles et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly
J Feenstra et al.
LANCET (2005)
Treatment outcomes and mortality of 94 patients with acromegaly
R Trepp et al.
ACTA NEUROCHIRURGICA (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®
P Caron et al.
CLINICAL ENDOCRINOLOGY (2004)
Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR
PJ Jenkins et al.
HORMONE RESEARCH (2004)
Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission
P De et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study
R Attanasio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly
C Beauregard et al.
CLINICAL ENDOCRINOLOGY (2003)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely et al.
LANCET (2001)
Pituitary surgery for the management of acromegaly
ER Laws et al.
HORMONE RESEARCH (2000)
Share Paper
